Table 1.
Center | City | Type of test | Test availability (years) | Number of retrieved tests | Data availability (years) |
---|---|---|---|---|---|
Institute of Tropical Medicine and International Health, Charité – Universitätsmedizin in Berlin | Berlin | in-house IFT | 2000–2010 | 204 | 2002–2018 |
in-house ELISA | 2000–2018 | 830 | |||
Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn | Bonn | in-house IFT | 2000–2010 | 201 | 2004–2018 |
commercial ELISA | 2011–2018 | 190 | |||
commercial RDT | 2000–2010 | 116 | |||
Bernhard Nocht Institute for Tropical Medicine | Hamburg | in-house IFT | 2000–2018 | 2641 | 2000–2018a |
in-house ELISA | 2000–2018 | 2654 | |||
PCRb | 2000–2018 | 200 | |||
Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich |
Munich | in-house IFT | 2000–2018 | 1670 | 2000–2018 |
in-house ELISA | 2000–2018 | 1668 | |||
PCRb | 2013–2018 | 35 | |||
Institute of Tropical Medicine, Medical Department, University Hospital Tübingen | Tuebingen | in-house IFT | 2009–2018 | 319 | 2009–2018 |
Total | 10,728 |
CD Chagas disease, ELISA Enzyme-linked immuno-sorbent assay, IFT Immunofluorescence test, PCR Polymerase chain reaction, RDT Rapid diagnostic test
aIndividual positive tests 2000–2018 and negative tests 2010–2018 could be retrieved
bHamburg offered a conventional PCR that was followed up by sequencing of the PCR product if positive, whereas Munich performed a conventional PCR that was followed up with an independent commercially available qPCR if positive (for details please see Supplement S2)